PAR 6.67% 24.0¢ paradigm biopharmaceuticals limited..

Ann: iPPS SIGNIFICANT OA PAIN REDUCTION AT 12 MONTHS, page-162

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,216 Posts.
    lightbulb Created with Sketch. 1375
    It depends on how close the sample mean is to the population mean. A larger trial is more representative of the population mean than a smaller trial, so the results of PARA 002 will be more representative of the population mean than say 008 and 005. The idea of running a smaller trial, particularly two of them is to provide a confidence estimate of the population mean so you can then determine the beta (or difference between placebo and treatment groups) to ensure the larger study is powered to achieve statistical significance.

    In other words, if the results of 008 are representative of the population mean, then a larger study will lead to a tightening of the confidence intervals and therefore greater separation, improving the chances of achieving statistical significance.


 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.0¢
Change
0.015(6.67%)
Mkt cap ! $83.98M
Open High Low Value Volume
22.5¢ 24.0¢ 22.5¢ $173.6K 743.6K

Buyers (Bids)

No. Vol. Price($)
8 99346 22.5¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 131244 5
View Market Depth
Last trade - 16.10pm 13/11/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.